Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs – a molecule that neutralizes the bugs’ ability to destroy the antibiotic.
Scientists at OSU were part of an international collaboration that demonstrated the molecule’s ability to inhibit expression of an enzyme that makes bacteria resistant to a wide range of penicillins.
The molecule is a PPMO, short for peptide-conjugated phosphorodiamidate morpholino oligomer. The enzyme it combats is known as New Delhi metallo-beta-lactamase, or NDM-1, and it’s accompanied by additional genes that encode resistance to most if not all antibiotics.
“We’re targeting a resistance mechanism that’s shared by a whole bunch of pathogens,” said Bruce Geller, professor of microbiology in OSU’s College of Science and College of Agricultural Sciences, who’s been researching molecular medicine for more than a decade. “It’s the same gene in different types of bacteria, so you only have to have one PPMO that’s effective for all of them, which is different than other PPMOs that are genus specific.”
The Oregon State study showed that in vitro the new PPMO restored the ability of an antibiotic — in this case meropenem, an ultra-broad-spectrum drug of the carbapenem class — to fight three different genera of bacteria that express NDM-1. The research also demonstrated that a combination of the PPMO and meropenem was effective in treating mice infected with a pathogenic strain of E. coli that is NDM-1 positive.
Results of the study, supported by a grant from the National Institutes of Health, were recently published in the Journal of Antimicrobial Chemotherapy.
Geller says the PPMO will likely be ready for testing in humans in about three years.
“We’ve lost the ability to use many of our mainstream antibiotics,” Geller said. “Everything’s resistant to them now. That’s left us to try to develop new drugs to stay one step ahead of the bacteria, but the more we look the more we don’t find anything new. So that’s left us with making modifications to existing antibiotics, but as soon as you make a chemical change, the bugs mutate and now they’re resistant to the new, chemically modified antibiotic.”
That progression, Geller explains, made the carbapenems, the most advanced penicillin-type antibiotic, the last line of defense against bacterial infection.
“The significance of NDM-1 is that it is destroys carbapenems, so doctors have had to pull out an antibiotic, colistin, that hadn’t been used in decades because it’s toxic to the kidneys,” Geller said. “That is literally the last antibiotic that can be used on an NDM-1-expressing organism, and we now have bacteria that are completely resistant to all known antibiotics. But a PPMO can restore susceptibility to antibiotics that have already been approved, so we can get a PPMO approved and then go back and use these antibiotics that had become useless.”
Receive an email update when we add a new ANTIBIOTIC RESISTANCE article.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Day Zero Diagnostics Awarded $6.2 Million in CARB-X Funding for Development of New Technology to Rapidly Diagnose Superbug Infections and Determine the Most Effective ...on May 11, 2020 at 1:31 pm
Day Zero Diagnostics, Inc., an infectious disease diagnostics company using genome sequencing and machine learning to combat the rise of antibiotic-re ...
- Antibiotic resistance may rise after COVID-19, as doctors struggle to treat secondary infectionson May 8, 2020 at 9:55 am
Doctors around the world are struggling to cure secondary illnesses patients contracted while battling coronavirus. Wired contributor Maryn McKenna joined CBSN to explain why this may contribute to ...
- Engineering natural selection in microbes has implications for biofuel production, addressing antibiotic resistanceon May 8, 2020 at 6:56 am
Scientists who study adaptation—or edit the genes of organisms—know the limitations inherent in conventional approaches to mutation that offer little opportunity to target individual genes without ...
- Antibiotic resistance is a dangerous consequence of our tendency to overuse drugson May 7, 2020 at 7:01 pm
Antibiotic resistance makes infections, like UTIs, more difficult to treat, and increases the risk of deadly infections in hospitals.
- Positive Facts One Should Know About Antibiotic Resistance Market for 2020on May 7, 2020 at 9:50 am
The antibiotics are the antimicrobial substance that is used to fight against the bacterial infection. Antibiotics are also used to cure several conditions including strep throat, urinary tract ...
- Why bacteria's resistance to antibiotics is a problem in a viral pandemicon May 6, 2020 at 9:28 am
Each year a particular kind of infection kills more than 35,000 people in the United States. Those deaths are caused by antibiotic-resistant bacteria.
- Rapid identification of pathogens, antibiotic resistance genes and plasmids in blood cultures by nanopore sequencingon May 6, 2020 at 2:10 am
Most studies on sepsis and BSIs report an increasing incidence over the last two decades 3, particularly among the immunocompromised, multimorbid, and elderly patients, or due to failure of empiric ...
- Antibiotic Resistance: The Patient Perspectiveon May 6, 2020 at 1:18 am
We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.
- Acquisition of Antibiotic-Resistant Gram-negative Bacteria in the Benefits of Universal Glove and Gown (BUGG) Cluster Randomized Trialon May 5, 2020 at 3:21 am
Universal glove and gown use in the intensive care unit was associated with a non–statistically significant decrease in acquisition of antibiotic-resistant gram-negative bacteria. Individual hospitals ...
via Bing News